Sabby Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Sabby Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-353	Closed	-$4.66M	–	202
2017 Q4	$4.66M	Sell	353 -796	-69%	-$93.5K	0.42%	37
2017 Q3	$11.7M	Buy	1,149 +686	+148%	+$73.5K	0.76%	20
2017 Q2	$4.64M	Hold	463	–	–	0.3%	41
2017 Q1	$5.6M	Buy	463 +271	+141%	+$33.2K	0.3%	45
2016 Q4	$2.15M	Hold	192	–	–	0.12%	98
2016 Q3	$2.55M	Buy	+192	New	+$18.4K	0.1%	109
2016 Q2	–	Sell	-908	Closed	-$6.55M	–	357
2016 Q1	$6.55M	Sell	908 -2,275	-71%	-$125K	0.33%	35
2015 Q4	$22.1M	Buy	3,183 +471	+17%	+$38.4K	1.22%	14
2015 Q3	$24.8M	Buy	2,712 +650	+32%	+$72.3K	1.02%	16
2015 Q2	$25.3M	Buy	2,062 +139	+7%	+$15.8K	0.92%	18
2015 Q1	$17.5M	Buy	+1,923	New	+$156K	0.73%	31
2014 Q3	–	Sell	-188	Closed	-$2.02M	–	314
2014 Q2	$2.02M	Buy	+188	New	+$13.1K	0.09%	104

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sabby Management's GWPH Position: Q4 2017 in Review

Sabby Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2017, closing a stake of 28,517 shares — an estimated $3.35M sold.

Sabby Management first reported a position in GWPH in Q1 2015 and held it in 7 quarters. The position peaked at $11.1M in Q4 2015. 204 funds tracked by Wall St. Rank hold GWPH as of Q4 2017.

Sabby Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
Sabby Management sold 28,517 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2017, an estimated $3.35M.
Sabby Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2015 and held it in 7 quarters.
Sabby Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $11.1M in Q4 2015.
204 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2017.

Based on Sabby Management's 13F filing for Q4 2017, filed 14 Feb 2018.